EBITDA

With 175 million lenses implanted, Alcon solidifies its market leadership. Discover the technology giving patients unprecedented freedom from glasses.

With a $6B M&A war chest and a new AI focus, Roper Technologies takes the stage at Morgan Stanley. Here’s what investors will be watching for.

UroGen's new bladder cancer drug sees rapid uptake post-reimbursement code, but a $153M loss and fresh debt highlight its high-stakes growth strategy.

In a strategic move, CCC Intelligent Solutions adds former Salesforce and Informatica exec John Schweitzer to its board, signaling a major push in AI and data.

SaaS growth expert Eric Shoemaker takes the helm at Keebo, aiming to scale its AI-powered platform amid soaring enterprise demand for cloud cost control.

As Middle East conflict roiled markets, 24/7 on-chain gold offered an immediate safe haven, challenging the dominance of traditional financial systems.

Zoetis is acquiring Neogen's genomics unit for $160M, a strategic move set to accelerate data-driven innovation in livestock and companion animal care.

Manhattan's top landlord promotes Harrison Sitomer from intern to President, signaling a focus on stability as it navigates a complex office market.

As Mike Eastwood retires, new CFO Gary Bischoping, a tech and finance veteran, is set to guide the company's ambitious AI transformation and next chapter of growth.

Hain Celestial completes sale of Terra and Garden of Eatin' to pay down debt, betting its future on the high-margin tea, yogurt, and baby food markets.

The healthcare firm reports a 56% revenue surge to $3.2B, but a "material weakness" in financial controls and a delayed SEC filing cast a shadow.

At MODEX 2026, KNAPP will unveil its AI-driven 'Brain' and award-winning 3D robots, promising a new era of intelligent, adaptive supply chains.

A new partnership between Japan's Marubeni and US firm Branford Castle promises to reshape the lower middle-market, offering small businesses global reach.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

A new DLA contract with REalloys seeks to onshore Samarium and Gadolinium production, vital for defense, using a breakthrough zero-waste technology.

New research shows a quarter of Americans want discounts for binge-watching, signaling a major shift away from rigid monthly streaming subscriptions.

With a new CTO and data from 6.6M patients, SBC Medical is building an AI-driven empire. But will this tech leap enhance care or displace workers?

Epson unveils a suite of printers, scanners, and projectors at HIMSS 2026, aiming to reduce errors, streamline workflows, and boost patient safety.

Norwegian Cruise Line reports strong 2025 earnings but a weak 2026 outlook, as its new CEO points to internal missteps and charts a course for recovery.

Hudbay's acquisition of Arizona Sonoran creates a massive copper district, aiming to fuel the US green transition amid market jitters and local scrutiny.